Related Experiment Videos
Myocardial perfusion scintigraphy: the evidence
S R Underwood1, C Anagnostopoulos, M Cerqueira
1Imperial College London, Royal Brompton Hospital, London, UK. r.underwood@imperial.ac.uk
Summary
Myocardial perfusion scintigraphy (MPS) is a highly accurate, non-invasive imaging technique for diagnosing and managing coronary artery disease. Despite its proven effectiveness and cost-benefits, MPS is underutilised in the UK, leading to long waiting times.
Area of Science:
- Cardiology
- Nuclear Medicine
- Diagnostic Imaging
Background:
- Coronary artery disease (CAD) diagnosis and management.
- Role of myocardial perfusion scintigraphy (MPS) in clinical practice.
- Evidence synthesis for guideline development.
Framework:
- Consensus conference findings.
- Endorsement by leading medical bodies.
- Informing UK National Institute of Clinical Excellence appraisals.
Implementation:
- MPS as a diagnostic tool for angina and myocardial infarction.
- Superior accuracy of MPS over exercise ECG for detecting ischaemia.
- MPS for risk stratification and guiding revascularisation decisions.
Implications:
- Improved clinical outcomes and cost-effectiveness.
- Enhanced resource utilisation in cardiovascular care.
- Addressing underutilisation of MPS in the UK and reducing waiting times.